Drug interactions and concurrent medications While AOD 9604 has not been shown to interact significantly with most medications, the research on drug interactions remains limited
Retrieved from Shipton, M
Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S
I was diagnosed with low B12 almost 2 years ago and while I had to diagnose myself, my GP was very helpful and seemingly knowledgeable after it was discovered